Antibiotic resistance (AR) poses a significant and escalating global threat, jeopardizing modern medicine's capacity to treat bacterial infections.  The widespread and often inappropriate use of antibiotics in human and veterinary medicine, coupled with inadequate sanitation and hygiene practices, fuels the selection and dissemination of resistant pathogens.  This has led to the emergence of multidrug-resistant (MDR) bacteria, including *Escherichia coli*, *Klebsiella pneumoniae*, and *Staphylococcus aureus*, which are increasingly intractable to treatment.  The global implications are profound, manifesting in increased morbidity and mortality rates, prolonged hospital stays, heightened healthcare costs, and reduced effectiveness of surgical procedures.  AR impacts disproportionately affect low- and middle-income countries lacking robust surveillance systems and access to effective antimicrobial stewardship programs.  Addressing this complex challenge necessitates a multi-pronged approach involving improved infection control, responsible antibiotic use, development of novel antimicrobial therapies, and strengthened global collaboration for surveillance and research.  Ultimately, mitigating AR requires a paradigm shift towards a more sustainable and responsible use of antibiotics to safeguard global public health.